Related by context. Frequent words. (Click for all words.) 64 Files Patent Infringement 60 Patent Lawsuit 60 Acacia Subsidiary Enters 58 Patent Licensing 58 Patent Infringement Case 58 Patent Infringement 58 alleging patent infringement 57 Advanced Analogic 57 patent litigations 57 Nano Proprietary 56 Declaratory Judgment 56 Speedus 56 Patent License Agreement 56 #cv# [001] 56 Patent Dispute 55 Teva Pharma 55 quotes/comstock/# * 55 Q2 Loss Narrows 55 Q1 Loss Widens 55 Nanya Technology Corporation 55 IPCom 55 Patent Infringement Lawsuit 55 Nasdaq ACTG announced 55 Announces Dismissal 55 Analysts Upgrades Downgrades 55 Koninklijke Philips Electronics 54 NV Organon 54 REC Wafer 54 Mosel Vitelic 54 AXYS Design Automation 54 Par Pharmaceuticals 54 Tessera patents 54 OPTi 54 Funai Electric 54 Q1 Profit Surges 54 VP Exercises Options 54 CFO Exercises Options 54 LongRun2 54 Telefonaktiebolaget LM Ericsson 54 Maxim Integrated 54 Posts 4Q Profit 54 Welcomes Analyst Initiation 54 Q2 Profit Surges 54 Siliconix 54 Integrated Device 54 Q3 Loss Widens 54 patent infringement litigation 54 Nanya Technology Corp. 54 Jumps Higher 54 Centillium Communications 53 GlaxoSmithKline plc GSK 53 Q3 Loss Narrows 53 Iridex 53 Declares Dividend Quick Facts 53 DepoMed 53 Fujitsu NEC 53 2Q Profit Jumps 53 Earnings Scorecard 53 Elan Pharma 53 MOSAID Technologies Inc. 53 Tessera Technologies 53 Approaching Resistance 53 CEO Exercises Options 53 Files Shelf Registration Statement 53 Files Patent 53 Centillium Communications Inc. 53 sublicensed 53 Q1 Loss Narrows 53 LecTec Corporation 53 Emblaze VCON 53 InnerCool Therapies 53 Global Locate 53 Immtech Pharmaceuticals Inc. 53 Derivative Litigation 52 ParthusCeva 52 Brion Technologies 52 submitted Marketing Authorization 52 Posts 4Q Loss 52 Mitel Networks Corporation 52 Pericom Semiconductor 52 TradeSignals 52 Klausner Technologies 52 Patent Suit 52 NASDAQ IPXL today 52 Announce Settlement 52 Marvell Semiconductor 52 Eyetech Pharmaceuticals 52 Dish Network DISH 52 Guides FY# Quick Facts 52 noninfringement 52 Corporation Nasdaq ACTG 52 Sankyo Co. 52 NASDAQ TEVA 52 commercialize telaprevir 52 Lowers Guidance 52 Posts 1Q 52 Develop Next Generation 52 TAP Pharmaceuticals 51 Antitrust Case 51 Argatroban 51 Bayer Schering